Inflammatory bowel disease. Part II: Clinical and therapeutic aspects.

Area of Science:

• Gastroenterology
• Immunology
• Genetics

Background:

• Ulcerative colitis and Crohn's disease, collectively known as inflammatory bowel disease (IBD), are increasingly recognized human illnesses with complex, multifactorial etiologies.
• While genetic, environmental, microbial, and immunologic factors are implicated, the precise mechanisms underlying IBD remain obscure.
• The incidence of ulcerative colitis is stable, whereas Crohn's disease shows a rising frequency, with a subset of cases presenting diagnostic challenges.

Purpose of the Study:

• To detail the clinical features, disease course, and management strategies for inflammatory bowel disease (IBD).
• To provide insights based on extensive clinical experience and recent literature (1988-1990) concerning ulcerative colitis and Crohn's disease.
• To highlight the importance of differential diagnosis and age-specific considerations in IBD management.

Main Methods:

• Review of clinical features, including symptoms, physical findings, and systemic complications of ulcerative colitis and Crohn's disease.
• Analysis of laboratory, radiologic, endoscopic, and pathologic findings relevant to IBD diagnosis.
• Examination of current therapeutic approaches, encompassing medical management, nutritional support, and surgical options.

Main Results:

• IBD presents with diverse clinical manifestations, necessitating differentiation from enterocolonic infections and other conditions.
• Management principles for ulcerative colitis and Crohn's disease are similar, emphasizing a comprehensive program tailored to individual patient responses.
• Therapeutic interventions include symptom relief medications, anti-inflammatory agents (sulfasalazine, 5-ASA compounds), antimicrobials, corticosteroids, and immunosuppressants (6-MP, azathioprine, cyclosporine).

Conclusions:

• Current medical therapy for IBD is supportive and facilitative, not curative, due to unknown etiology.
• Treatment strategies involve a combination of pharmacologic agents, nutritional support, and, in some cases, surgical intervention.
• Understanding individual patient needs and therapeutic responses is crucial for effective IBD management.